Rabbit Polyclonal CD137 antibody. Suitable for IHC-P and reacts with Rat samples. Cited in 6 publications. Immunogen corresponding to Synthetic Peptide within Human TNFRSF9 aa 100-200 conjugated to Keyhole Limpet Haemocyanin.
View Alternative Names
CD137, ILA, TNFRSF9, Tumor necrosis factor receptor superfamily member 9, 4-1BB ligand receptor, CDw137, T-cell antigen 4-1BB homolog, T-cell antigen ILA
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD137 antibody (AB203391)
Immunohistochemical analysis of formalin-fixed paraffin-embedded rat brain tissue, labeling CD137 using ab203391 at a 1/600 dilution, followed by conjugation to the secondary antibody and DAB staining.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD137 plays an important role in T cell activation and survival. It is a member of a receptor-ligand system that enhances immune cell functions. CD137 is part of a receptor complex that when bound by its ligand CD137L promotes cell proliferation and cytokine production. It also supports the development of memory T cells contributing to the body's ability to mount long-term immune responses.
Pathways
CD137 takes part in the NF-kB signaling and MAPK pathways. These pathways are vital for regulating immune responses and inflammation. CD137 signaling through these pathways involves interaction with proteins such as TRAF1 and TRAF2 which help mediate downstream effects critical for cell survival and proliferation. These interactions enhance the body's defense against pathogens and tumors.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in immunology 13:896744 PubMed35911679
2022
Applications
Unspecified application
Species
Unspecified reactive species
International immunopharmacology 88:106905 PubMed32905970
2020
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 6:eaaz7492 PubMed32426485
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of obesity (2005) 42:721-727 PubMed29188818
2017
Applications
Unspecified application
Species
Unspecified reactive species
Cancer prevention research (Philadelphia, Pa.) 10:684-693 PubMed29018057
2017
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 16:1262-1268 PubMed28627614
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com